Unitaid and partners cut cost of portable AI-compatible X-ray device, bringing TB screening closer to communities
May 20, 2025: Unitaid and the Clinton Health Access Initiative (CHAI) today announced a new agreement to…
Regional Workshop to accelerate the uptake of the latest WHO guidelines on DR-TB management in South East Asia and Western Pacific regions.
Every year around half a million people develop Rifampicin Resistant/Multidrug Resistant tuberculosis (RR/MDR-TB). Today, RR/MDR-TB is a…
KNCV Ethiopia Provides Practical training on Clinical Monitoring Tools for South Ethiopia Healthcare Providers to Enhance DR-TB care
The Unitaid-funded ASCENT DR-TB project, implemented in Ethiopia by KNCV Ethiopia in collaboration with the Federal Ministry…
KNCV Ethiopia Boosts DR-TB Safety Monitoring in South Ethiopia with Medical Equipment Donation
Arbaminch, Ethiopia – KNCV Ethiopia, through the Unitaid-funded ASCENT DR-TB project in collaboration with the Federal Ministry of…
KNCV Ethiopia Trains Healthcare Providers in South Ethiopia Region on Active Drug Safety Monitoring to Enhance DR-TB care
Arbaminch, Ethiopia – April 8-11, 2025 – KNCV Ethiopia, under the Unitaid-funded ASCENT DR-TB project, delivered a…
Yayasan KNCV Indonesia – Job Aids Resources 2025
The ASCENT DR-TB Partner Yayasan KNCV Indonesia (YKI) created a series of job aids (flip charts) to…
Treatment Action Group – TAG Community Resources 2025
On Monday 31 of March, 2025, the ASCENT DR-TB Consortium Partner Treatment Action Group (TAG) launched the…
Improving treatment literacy and strengthening community partnerships
According to the WHO Global TB Report 2023, 825,000 people were treated for rifampicin resistant/multidrug resistant tuberculosis (RR/MDR-TB) between…
Stakeholders Consultative Workshop and Kick-off Meeting in Ethiopia
The first stakeholder consultative workshop and kick-off meeting in Ethiopia was successfully conducted on January 26 and…
Regional Workshop on accelerating the uptake of the latest WHO guidance on the management of DR-TB in the African Region
Every year around half a million people develop Rifampicin Resistant/Multidrug Resistant tuberculosis (RR/MDR-TB). RR/MDR-TB is a massive…